Return to Article Details Liposomal clodronate combined with Cisplatin or Sorafenib inhibits hepatocellular carcinoma cell proliferation, migration and invasion by suppressing FOXQ1 expression Download Download PDF
Themes by Openjournaltheme.com Themes by Openjournaltheme.com